公开(公告)号：WO2023042096A1

公开(公告)日：2023-03-23

申请号：PCT/IB2022/058670

申请日：2022-09-14

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： HOEFINGHOFF, Joris ,  LEIDENMUEHLER, Peter ,  GANGADHARAN, Bagirath ,  HAIDER, Norbert ,  NAGY, Andras ,  LI, Zhaoyang

IPC: A61K38/47 ,  A61M5/44 ,  A61P37/00 ,  C07K16/06

Abstract: Provided is a concentrated pharmaceutical formulation of an immune globulin (IG), and convenient methods for the subcutaneous administration of this pharmaceutical formulation in a warmed state. Such products can be used in methods of treating IG-treatable diseases or conditions. Also provided are combinations, compositions and kits containing an immune globulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration.

公开(公告)号：EP4401758A1

公开(公告)日：2024-07-24

申请号：EP22783017.1

申请日：2022-09-14

Applicant: Takeda Pharmaceutical Company Limited

Inventor： HOEFINGHOFF, Joris ,  LEIDENMUEHLER, Peter ,  GANGADHARAN, Bagirath ,  HAIDER, Norbert ,  NAGY, Andras ,  LI, Zhaoyang

IPC: A61K38/47 ,  A61M5/44 ,  A61P37/00 ,  C07K16/06

CPC classification number: A61K38/47 ,  A61P37/00 ,  C12Y302/01035 ,  C07K16/00 ,  A61K39/39591 ,  A61K2039/50520130101 ,  A61K2039/5420130101 ,  C07K2317/9020130101 ,  C07K2317/2120130101